Del. Judge Orders Rework For Melinta Ch. 11 Sale Plan
Antibiotics developer Melinta Therapeutics Inc. saw its fast-moving Chapter 11 sale plans sidelined for revisions Tuesday, after a Delaware bankruptcy judge said the proposal needs more time for stakeholder review and...To view the full article, register now.
Already a subscriber? Click here to view full article